CNBC
Eli Lilly blows past estimates, hikes guidance as Zepbound, Mounjaro sales soar
Eli Lilly said the guidance increase was primarily driven by the strong performance of Mounjaro and Zepbound and comes in part due to "improved clarity" into the company's production expansions ...
2 days ago